Revive Therapeutics 

€0.01
40
+€0.01+100% Wednesday 14:58

Statistik

Harga Tertinggi Hari Ini
0.01
Harga Terendah Hari Ini
0.01
52M Tinggi
-
52M Rendah
-
Volume
9,000
Rata-Rata Volume
-
Kap Pasar
2.38M
Rasio P/E
-
Hasil Dividen
-
Dividen
-

Pendapatan

27OctDiharapkan
Q3 2020
Q4 2020
Q1 2021
Q3 2021
Q4 2021
Q1 2022
Q3 2022
-0.02
-0.02
-0.01
-0
EPS yang Diharapkan
T/A
EPS Aktual
-0.0039

Orang Juga Mengikuti

Daftar ini didasarkan pada daftar pantauan orang-orang di Stock Events yang mengikuti 31R.F. Ini bukan rekomendasi investasi.

Peserta

Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.

Tentang

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is based in Toronto, Canada.
Show more...
CEO
Mr. Michael Frank
Negara
CA
ISIN
CA7615161030
WKN
000A2AP4F

Daftar